🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Somnolence Disorder, Excessive

a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial NCT06252571Phase 21 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: - Melatonin - Active light ttherapy, - Placebo drug - Placebo light therapy Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Solriamfetol for the Treatment of Multiple Sclerosis Fatigue NCT06170970Phase 21 site📍 Baltimore Johns Hopkins University · Tests: Solriamfetol, Placebo Digital Sleep Program for College Students with Insomnia NCT06853106NA1 site📍 Taipei Taipei Medical University · Tests: Waitlist control group, digital-based multimodal sleep management program A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence NCT07598708Phase 2, Phase 323 sites📍 Birmingham📍 Colorado Springs📍 Brandon Centessa Pharmaceuticals (UK) Limited · Tests: cleminorexton, Placebo Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy NCT06279247n/a1 site📍 Jinan Qilu Hospital of Shandong University SUNOSI® (Solriamfetol) Pregnancy Registry NCT06413420n/a2 sites📍 Morrisville📍 Wilmington Axsome Therapeutics, Inc. · Tests: Sunosi (solriamfetol), Other prescription wake-promoting medications or stimulants, No treatment A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy NCT07613710Phase 12 sites📍 Helsinki📍 Turku H. Lundbeck A/S · Tests: Lu AH69593, Placebo A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304) NCT07540897Phase 320 sites📍 Brandon📍 Miami📍 Winter Park Alkermes, Inc. · Tests: ALKS 2680 Dose 1, ALKS 2680 Dose 2, Placebo A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy NCT07493265Phase 257 sites📍 Santa Ana📍 Brandon📍 Medley Eisai Inc. · Tests: E2086, Placebo Decreasing Nightmares in Adults With Narcolepsy NCT06383806NA1 site📍 Salt Lake City University of Utah · Tests: Imagery Rehearsal Therapy (IRT) A Study Assessing Adult Patients Referred to an NHS Sleep Service With Suspected Obstructive Sleep Apnoea. This Study Aims to Compare the Sunrise Wearable Diagnostic Device Performance and Potential Inclusion in a NHS Diagnostic Pathway With Oximetry and WatchPAT Which Are Currently Used. NCT07269483NA1 site📍 Bristol Virginia Hawkins · Tests: WatchPAT 300, Oximetry, Sunrise Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers NCT07217769NA1 site📍 Pittsburgh University of Pittsburgh · Tests: No-nap, 15-min nap, 30-min nap, 45-min nap, 60-min nap A Study of Pitolisant in Patients With Prader-Willi Syndrome NCT06366464Phase 357 sites📍 Los Angeles📍 Sacramento📍 San Diego Harmony Biosciences Management, Inc. · Tests: Pitolisant tablet, Placebo tablet A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age NCT07082829Phase 13 sites📍 Lincoln📍 Eatontown📍 New York Centessa Pharmaceuticals (UK) Limited · Tests: ORX142 Tablets, Placebo Tablets Promoting Teenage Sleep for Improved Mental Health and School Performance NCT06306092NA1 site📍 Kristianstad Kristianstad University · Tests: Sleep on Schedule, Technology restriction Extended-release Sodium Oxybate in Children NCT06809803Phase 21 site📍 Redwood City Stanford University · Tests: Extended-release sodium oxybate, Non-extended-release oxybates Mainz Register of Patients With Sleep Disorders NCT05321355n/a1 site📍 Mainz Johannes Gutenberg University Mainz · Tests: Implantation of vagus nerve stimulation according to clinical indication A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia NCT07006233NA1 site📍 Macquarie Park University of Sydney · Tests: Whole Food Ketogenic Diet, Whole Food Diet A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH NCT07625280Phase 315 sites📍 Birmingham📍 Irvine📍 Long Beach Jazz Pharmaceuticals · Tests: Xywav, Placebo Test-retest Reliability of the Maintenance of Wakefulness Test in Participants With Hypersomnolence NCT07120061NA4 sites📍 Bordeaux📍 Montpellier📍 Paris University Hospital, Bordeaux · Tests: First MWT, second MWT, actimetry The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders NCT06797284NA1 site📍 Suzhou Second Affiliated Hospital of Soochow University · Tests: Transcranial Magnetic Stimulation Constitution of a Clinical, Neurophysiological and Biological Cohort for Chronic Sleep Disorders Responsible of Hypersomnolence NCT03998020NA1 site📍 Montpellier University Hospital, Montpellier · Tests: scale of severity, blood sample A Study of TAK-360 in Adults With Idiopathic Hypersomnia NCT06812078Phase 229 sites📍 Redwood City📍 Santa Ana📍 Colorado Springs Takeda · Tests: TAK-360, Placebo A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) NCT07500090Phase 342 sites📍 Birmingham📍 Peoria📍 Redwood City Harmony Biosciences Management, Inc. · Tests: HBS-301 tablet, Placebo Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia NCT05773872NA1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: Questionary Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal NCT06872593NA1 site📍 Zurich Stefan Lakämper · Tests: CPAP-withdrawal, Test Sequence A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy NCT07675135Phase 353 sites📍 Birmingham📍 Mobile📍 Peoria Harmony Biosciences Management, Inc. · Tests: HBS-301, Placebo Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia NCT06484348NA2 sites📍 Clermont-Ferrand📍 Lyon Hospices Civils de Lyon · Tests: Monitoring of eating behaviors, Monitoring of sleep/wake rhythm, Measure of nocturnal sleep parameters, Measure of slee… A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia NCT06752668Phase 237 sites📍 Auburn📍 Chandler📍 Scottsdale Centessa Pharmaceuticals (UK) Limited · Tests: ORX750, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy